2017
DOI: 10.1016/j.parkreldis.2016.11.011
|View full text |Cite
|
Sign up to set email alerts
|

Association between Parkinson's disease and risk of colorectal cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
18
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 23 publications
(22 citation statements)
references
References 33 publications
4
18
0
Order By: Relevance
“…Interestingly, a tyrosine kinase inhibitor of platelet-derived growth factor receptor, imatinib, was widely used to treat CML and significantly ameliorated survival in murine lupus autoimmune disease 65 . In addition, association between CRC and PD has been reported in several observational cohorts 66, 67 . Collectively, these findings strongly support our hypothesis that human complex diseases sharing similar microbiome features might be mechanically correlated.…”
Section: Discussionmentioning
confidence: 94%
“…Interestingly, a tyrosine kinase inhibitor of platelet-derived growth factor receptor, imatinib, was widely used to treat CML and significantly ameliorated survival in murine lupus autoimmune disease 65 . In addition, association between CRC and PD has been reported in several observational cohorts 66, 67 . Collectively, these findings strongly support our hypothesis that human complex diseases sharing similar microbiome features might be mechanically correlated.…”
Section: Discussionmentioning
confidence: 94%
“…We found two studies regarding PD and colorectal cancer (CRC) (Boursi et al, 2016;Xie et al, 2016). The first one included an extensive series of 22,093 CRC cases, in which PD was identified in 117 (0.5%).…”
Section: Parkinson Diseasementioning
confidence: 99%
“…Regarding some particular tumors, Xie et al (2016) studied the possible mechanisms related to colorectal cancer and PD. Different hypotheses have been proposed to explain the inverse association between both conditions (Louis et al, 2014).…”
Section: Parkinson's Diseasementioning
confidence: 99%
“…These symptoms were found to be elevated in 24.3% of the PD patients versus 5.3% of controls. Another example of a potential interplay between the gut and PD relates to the reduced risk of colorectal cancer as reported by 2 studies with high numbers of patients and matched controls [41, 42]. The assumption that PD correlates also with intestinal dysbiosis was recently tested in a mouse model of the disease: mice that overexpressed α-synuclein displayed decreased pathophysiological signs upon antibiotics treatment [43].…”
Section: Impact Of Gut Microbiota On Neurodegenerative Diseasesmentioning
confidence: 99%
“…As far as changes observed in human PD patients are concerned, the results are conflicting, which might be due to differences in sample collection, preparation, and analysis. One example where those discrepancies are obvious is the family Prevotellaceae: 2 reports describe a decreased number in fecal samples of PD patients [41, 44], whereas 2 other studies report no significant deviation from healthy controls [45, 46] and 1 investigation describes even elevated numbers of this family in PD patients [47]; however, samples here were taken from the oral cavity. An example where the literature seems to be more consistent is the family Lactobacillaceae, with at least 3 reports showing elevated numbers [45-47].…”
Section: Impact Of Gut Microbiota On Neurodegenerative Diseasesmentioning
confidence: 99%